Artialis is a partner in the APPROACH project

(...) "In a bid to stimulate the development of much needed treatments for osteoarthritis, a consortium of 24 partners comprising pharmaceutical companies, biotech companies, academic institutions, not-for-profit organizations, small and medium enterprises (SMEs) and public bodies have joined forces in the pan-European APPROACH (Applied Public-Private Research enabling OsteoArthritis Clinical Headway) project, with total research funding of 15 million Euros. Of this amount, 7.5 million Euros will come from the European Innovative Medicines Initiative (IMI) and 7.5 million Euros in the form of ‘in kind’ contributions from participating members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)." (...)